Chin-Hsien Tsai

Title: Innovations by Chin-Hsien Tsai

Introduction

Chin-Hsien Tsai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biomedical research, particularly in the area of cancer prognosis and treatment. With a total of 3 patents, his work has the potential to impact the lives of many patients.

Latest Patents

One of his latest patents focuses on biomarkers for predicting prostate cancer progression. This invention relates to biomarkers, methods, and assay kits designed to predict prognosis and monitor the progression of prostate cancer. The biomarkers include a glycosyltransferase gene product, specifically core 1 beta-3-galactosyltransferase (C1GALT1) and/or ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1), along with its saccharide substrate/product and/or a galectin-4 gene product. Another significant patent involves the development of a standardized and effect-optimized herbal extract for treating androgen-stimulated disorders. This composition includes a standardized extract and outlines methods for treating such disorders effectively.

Career Highlights

Chin-Hsien Tsai is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to collaborate with other leading researchers in the field, enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Pei-wen Hsiao and Shih-Chuan Hsieh. Their collaborative efforts contribute to the advancement of research and innovation in their respective fields.

Conclusion

Chin-Hsien Tsai's innovative work in the realm of cancer research and herbal medicine showcases his dedication to improving patient outcomes. His patents reflect a commitment to scientific advancement and the potential for significant medical breakthroughs.